VISTAGEN THERAPEUTICS, INC. Foreign Currency Transaction Gain (Loss), before Tax
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Foreign Currency Transaction Gain (Loss), before Tax of $0 for the 12-month period ending 2017-03-31, per its 10-K filed 2017-06-29.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2017-06-29
- VISTAGEN THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- VISTAGEN THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2016 was $6.40K, a 89.94% decline from fiscal 2015.
- VISTAGEN THERAPEUTICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2015 was $63.60K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|
| 2017-03-31 | $0.00 10-K · filed 2017-06-29 |
| 2016-03-31 | $6.40K 10-K · filed 2017-06-29 |
| 2015-03-31 | $63.60K 10-K · filed 2016-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |